TWO · Financial Statements

Welgene Biotech Co.,Ltd. (6661.TWO) Financial Statements

$17.20 TWO: 6661.TWO Market Cap $386.85M

Full income statement, balance sheet, and cash flow statement for Welgene Biotech Co.,Ltd. (6661.TWO), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
6661.TWO Overview 6661.TWO Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.